Aug 31, 2010 - Results of Phase II trial of NGR-hTNF in liver cancer published by the British Journal of Cancer
Aug 25, 2010 - Results of Phase II trial of NGR-hTNF in colorectal cancer published by the European Journal of Cancer
Aug 5, 2010 - MolMed Board of Directors approves the financial report for the first half of year 2010
Aug 2, 2010 - Final results of MolMed share capital increase with pre-emptive rights
Jul 20, 2010 - MolMed Share Capital Increase via Pre-emptive Rights Offering - Completion of the Subscription Period
Approximately 98% of the offered ordinary shares has been subscribed - 2,076,594 subscription rights that were not exercised, valid for the subscription of 2,076,594 ordinary shares, equal to approximately 2% of the offered ordinary shares, will be offered on the Italian Stock Exchange during the trading sessions of July 22, 23, 26, 27 and 28, 2010
Jun 24, 2010 - MolMed share capital increase via pre-emptive rights offering
Jun 7, 2010 - MolMed leads a project awarded a € 1.4 million grant by Regione Lombardia for optimisation of TK therapy manufacturing process
Jun 5, 2010 - MolMed presents at ASCO 2010 follow-up data of a Phase II trial of its TK therapy for leukaemia, showing its direct anti-leukaemic effects and its contribution to thymic activity renewal
May 24, 2010 - MolMed receives FDA clearance of IND to initiate a Phase III trial of NGR-hTNF in mesothelioma in the United States
May 10, 2010 - MolMed Board of Directors approves the interim financial statements for the first quarter of 2010
Apr 26, 2010 - MolMed Shareholders’ Meeting approves the Financial Statements 2009
Apr 21, 2010 - Results of Phase II trial of NGR-hTNF in mesothelioma published by the Journal of Clinical Oncology
Apr 13, 2010 - Resignation of Statutory Auditor
Apr 13, 2010 - MolMed starts Phase III trial of NGR-hTNF in mesothelioma
Mar 24, 2010 - Integration to the press release of March 22, 2010
Mar 22, 2010 - MolMed Board of Directors convenes Shareholders Meeting
Mar 15, 2010 - MolMed Board of Directors approves the draft financial statements for year 2009
ARCHIVE
|
2010 |
2009 |
2008 |
2007 |
2005 |
2004 |
2003 |
